Endobronchial ultrasound doppler image features correlate with mRNA expression of hif1-α and vegf-c in patients with non-small-cell lung cancer

Journal of Thoracic Oncology

Volumn 7, Issue 11, 2012, Pages 1661-1667

  Nakajima, Takahiro ^a,b,c   Anayama, Takashi ^a   Koike, Terumoto ^a   Shingyoji, Masato ^b   Castle, Lianne ^a   Kimura, Hideki ^b   Yoshino, Ichiro ^c   Yasufuku, Kazuhiro ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b CHIBA CANCER CENTER   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Doppler mode imaging; Endobronchial ultrasound; Lymph node metastasis; Non small cell lung cancer; Tumor angiogenesis and lymphangiogenesis

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN C;

ARTICLE; BLOOD FLOW; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; ENDOBRONCHIAL ULTRASONOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSBRONCHIAL ASPIRATION;

EID: 84867898860     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318265b4df     Document Type: Article

References (39)

1. Gu P, Zhao YZ, Jiang LY, Zhang W, Xin Y, Han BH. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer 2009;45:1389-1396.
2. Adams K, Shah PL, Edmonds L, Lim E. Test performance of endo-bronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax 2009;64:757-762.
3. Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011;142:1393-400.e1.
4. Memoli JS, El-Bayoumi E, Pastis NJ, et al. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest 2011;140:1550-1556.
5. Fujiwara T, Yasufuku K, Nakajima T, et al. The utility of sonographic features during endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with lung cancer: a standard endobron-chial ultrasound image classifcation system. Chest 2010;138:641-647.
6. Nakajima T, Anayama T, Shingyoji M, Kimura H, Yoshino I, Yasufuku K. Vascular image patterns of lymph nodes for the prediction of meta-static disease during EBUS-TBNA for mediastinal staging of lung cancer. J Thorac Oncol 2012;7:1009-1014.
7. Adler DD, Carson PL, Rubin JM, Quinn-Reid D. Doppler ultrasound color fow imaging in the study of breast cancer: preliminary fndings. Ultrasound Med Biol 1990;16:553-559.
8. Zhou J, Zhu SY, Liu RC, Luo F, Shu DX. Vascularity index of laryngeal cancer derived from 3-D ultrasound: a predicting factor for the in vivo assessment of cervical lymph node status. Ultrasound Med Biol 2009;35:1596-1600.
9. Sawhney MS, Debold SM, Kratzke RA, Lederle FA, Nelson DB, Kelly RF. Central intranodal blood vessel: a new EUS sign described in medias-tinal lymph nodes. Gastrointest Endosc 2007;65:602-608.
10. Nakajima T, Shingyouji M, Nishimura H, et al. New endobronchial ultrasound imaging for differentiating metastatic site within a mediastinal lymph node. J Thorac Oncol 2009;4:1289-1290.
11. Voit C, Van Akkooi AC, Schäfer-Hesterberg G, et al. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol 2010;28:847-852.
12. Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and infuences progression of non-small cell lung carcinoma. Clin Cancer Res 1997;3:861-865.
13. Koshikawa N, Iyozumi A, Gassmann M, Takenaga K. Constitutive upregu-lation of hypoxia-inducible factor-1alpha mRNA occurring in highly met-astatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure. Oncogene 2003;22:6717-6724.
14. Wang Y, Dan HJ, Fan JH, Wen SB. Evaluation of the correlation between colour power Doppler fow imaging and vascular endothelial growth factor in breast cancer. J Int Med Res 2010;38:1077-1083.
15. Chen CN, Lin JJ, Lee H, et al. Association between color doppler vas-cularity index, angiogenesis-related molecules, and clinical outcomes in gastric cancer. J Surg Oncol 2009;99:402-408.
16. Pore N, Gupta AK, Cerniglia GJ, et al. Nelfnavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Cancer Res 2006;66:9252-9259.
17. Yuan A, Yu CJ, Kuo SH, et al. Vascular endothelial growth factor 189 mRNA isoform expression specifcally correlates with tumor angiogen-esis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol 2001;19:432-441.
18. Rusch V W, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P; Members of IASLC Staging Committee. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classifcation for lung cancer. J Thorac Oncol 2009;4:568-577.
19. Rasband, WS. Image J. Bethesda, MD: U. S. National Institutes of Health, http://imagej.nih.gov/ij/, 1997-2011. Accessed March 1, 2011.
20. Yasufuku K, Nakajima T, Motoori K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 2006;130:710-718.
21. Nakajima T, Yasufuku K, Iyoda A, et al. The evaluation of lymph node metastasis by endobronchial ultrasound-guided transbronchial needle aspiration: crucial for selection of surgical candidates with metastatic lung tumors. J Thorac Cardiovasc Surg 2007;134:1485-1490.
22. Nakajima T, Yasufuku K. How I do it-optimal methodology for multidirectional analysis of endobronchial ultrasound-guided transbronchial needle aspiration samples. J Thorac Oncol 2011;6:203-206.
23. Nakajima T, Anayama T, Koike T, et al. Simultaneous isolation of total RNA, DNA, and protein using samples obtained by EBUS-TBNA. J Bronchol Intervent Pulmonol 2011;18:301-305.
24. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008;358:2039-2049.
25. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphan-giogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-583.
26. Ogawa K, Chiba I, Morioka T, et al. Clinical signifcance of HIF-1alpha expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Anticancer Res 2011;31:2351-2359.
27. Yasuda H, Nakayama K, Watanabe M, et al. Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. Clin Cancer Res 2006;12:6748-6757.
28. Yasuda H, Yamaya M, Nakayama K, et al. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. J Clin Oncol 2006;24:688-694.
29. Shinohara ET, Maity A. Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alter the tumor microenvironment. Curr Mol Med 2009;9:1034-1045.
30. Anagnostou VK, Tiniakos DG, Fotinou M, Achimastos A, Syrigos KN. Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patients. Virchows Arch 2011;458:331-340.
31. Saintigny P, Kambouchner M, Ly M, et al. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Lung Cancer 2007;58:205-213.
32. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical signifcance of vascular endothelial growth factor C and vascular endo-thelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 2003;97:457-464.
33. Kajita T, Ohta Y, Kimura K, et al. The expression of vascular endothe-lial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 2001;85:255-260.
34. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007;109:1010-1017.
35. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355:2542-2550.
36. Los M, Roodhart JM, Voest EE. Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist 2007;12:443-450.
37. Altorki N, Lane ME, Bauer T, et al. Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resect-able non-small-cell lung cancer. J Clin Oncol 2010;28:3131-3137.
38. Nakajima T, Yasufuku K, Suzuki M, et al. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration. Chest 2007;132:597-602.
39. Nakajima T, Yasufuku K, Takahashi R, et al. Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasound-guided transbronchial needle aspiration. Respirology 2011;16:90-94.